eurological signs in very high-risk infants and developmental outcome at school age

Completed

• Conditions: cerebral palsy; 10010335

• Registration Number: NL-OMON50365
• Lead Sponsor: niversitair Medisch Centrum Groningen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 July 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 68

Inclusion Criteria

For the patients: participation in the LEARN2MOVE 0-2years project (L2M; n=43).
Inclusion criteria for the original LEARN2MOVE 0-2 years project were age zero
to nine months CA at enrolment and the presence of at least one of the
following conditions:
(1) cystic periventricular leukomalacia,
(2) parenchymal lesion of the brain,
(3) severe neonatal hypoxic-ischaemic encephalopathy with brain lesions on MRI,
(4) neurological dysfunctions suggestive of the development of CP.
For the control group:
(1) typically developing
(2) age 7-10 years
(3) attending mainstream education

Exclusion Criteria

For the patients: Exclusion criteria of the LEARN2MOVE 0-2 years project were:
- Children with severe congenital disorders
- Caregivers having insufficient understanding of the Dutch language
For the controls:
- presence of a complicated neonatal history
- presence of a neurodevelopmental disorder, such as cerebral palsy,
developmental coordination disorder, autism spectrum disorder, learning
disability, or attention deficit hyperactivity disorder
- Presence of the complex form of minor neurological dysfunction (MND)
- Caregivers having insufficient understanding of the Dutch language

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified